Overall survival in elderly patients with colorectal cancer: A population-based study in the Caribbean. (June 2017)

• Record Type: Journal Article
• Authors: Joachim, Clarisse; Godaert, Lidvine; Dramé, Moustapha; Véronique-Baudin, Jacqueline; Macni, Jonathan; Smith-Ravin, Juliette; Novella, Jean-Luc; Mahmoudi, Rachid
• Is Part Of: Cancer epidemiology. Volume 48(2017:Jun.)
• Page Start: 85
• Page End: 91
• Publication Date: 2017-06
• Subjects: Colorectal cancer -- Chemotherapy -- Elderly -- Cancer survival -- Caribbean; Cancer -- Epidemiology -- Periodicals; Cancer -- Prevention -- Periodicals; Cancer -- Diagnosis -- Periodicals; Carcinogenesis -- Periodicals; 616.994005
• DOI: 10.1016/j.canep.2017.03.005
• Languages: English
• ISSNs: 1877-7821

Abstract

Highlights: We evaluated all incident cases of invasive colorectal cancer diagnosed in Martinique between 01/01/1993 and 31/12/2012. We analysed age at diagnosis, sex, histology, zone of residence, subsite, stage and chemotherapy. Our study highlights the role of Population-based cancer registries in evaluating cancer survival in the Caribbean. Abstract: Background: Population-based Cancer registries (PBCR) play an important role in cancer surveillance and research. The aim of this study was to examine overall survival in elderly patients with colorectal cancer (CRC) by analysing data from the Martinique PBCR between 1993 and 2012. Methods: The log-rank test was used to assess the statistical differences of the survival curves by each categorical variable: age at diagnosis, sex, histology, zone of residence, subsite, stage at diagnosis, and chemotherapy. A multivariable Cox model was performed to identify independent prognostic factors for overall survival in elderly patients with colorectal cancer. Results: Among 2230 patients included in the study, 60.8% were aged ≥ 65 years; mean age at diagnosis of these patients was 75.7 ± 7.2 years. For the period 2008–2012, 532 elderly patients were analysed; mean age of those receiving chemotherapy was 73.0 ± 0.4 versus 77.9 ± 0.4 years for those not receiving chemotherapy (p < 0.0001). Stage at diagnosis was evaluated in 87.8% (467/532) of patients; 63.0% (294/467) had stage III–IV and 49.3% of these patients (145/294) received chemotherapy. Chemotherapy was less frequently prescribed in patients aged 75–84 and ≥85 years as compared to those aged 65–74 years (41.1% and 15.0% versus 64.6% respectively; p < 0.0001). Stage III–IV at diagnosis (HR = 5.25; 3.70–7.45; p < 0.0001), and not receiving chemotherapy (HR = 3.05; 2.23–4.16; p < 0.0001), were independent prognostic factors for overall survival. Conclusion: Our study highlights the role of PBCR in evaluating cancer survival and patterns of care in elderly people of the French West- Indies. Chemotherapy was less frequently prescribed among the elderly